Novel Approaches to Target MECOM/EVI1 in AML

NCT05839392 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

AML, Adult

Interventions

BIOLOGICAL: Biological characterization of AML with MECOM or atypical 3q26 rearrangements

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto